pk/pd modeling and simulation approach (Shionogi)
90
Structured Review
Shionogi
pk/pd modeling and simulation approach
Pk/Pd Modeling And Simulation Approach, supplied by Shionogi, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/simulator+pd+model/pk+pd+modeling+and+simulation+approach/pm19904828-11-4-46
Average 90 stars, based on 1 article reviews
Pk/Pd Modeling And Simulation Approach, supplied by Shionogi, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/simulator+pd+model/pk+pd+modeling+and+simulation+approach/pm19904828-11-4-46
Average 90 stars, based on 1 article reviews
pk/pd modeling and simulation approach - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
In Vitro:Article Title: Pharmacokinetic/pharmacodynamic modeling and simulation to determine effective dosage regimens for doripenem. Article Snippet: Journal of Pharm 2009 Wiley-Liss ABSTRACT: The aim of this study was to obtain information on effective dosage regimens of doripenem by a modeling and simulation approach based on pharmacokinetic (PK)/pharmacodynamic (PD) theory.. The PK/PD model we have already developed was modified to explain in vitro bactericidal kinetics of doripenem for several Pseudomonas aeruginosa strains.. Timecourse profiles of bacterial counts in patients infected with P. aeruginosa were simulated for typical clinical dosage regimens in Japan considering the variability of PK and the patients’ backgrounds by a Monte Carlo simulation. In Vivo:Article Title: Pharmacokinetic/pharmacodynamic modeling and simulation to determine effective dosage regimens for doripenem. Article Snippet: Journal of Pharm 2009 Wiley-Liss ABSTRACT: The aim of this study was to obtain information on effective dosage regimens of doripenem by a modeling and simulation approach based on pharmacokinetic (PK)/pharmacodynamic (PD) theory.. The PK/PD model we have already developed was modified to explain in vitro bactericidal kinetics of doripenem for several Pseudomonas aeruginosa strains.. Timecourse profiles of bacterial counts in patients infected with P. aeruginosa were simulated for typical clinical dosage regimens in Japan considering the variability of PK and the patients’ backgrounds by a Monte Carlo simulation. |